Featured in Journal Watch: Successful Clearance of Hepatitis C Virus Associated with Lower Mortality — Physician’s First Watch
Featured in Journal Watch: Successful Clearance of Hepatitis C Virus Associated with Lower Mortality
By The Journal Watch Editors
Patients with hepatitis C who achieved sustained virologic response (SVR) had lower risk for all-cause mortality, according to a JAMA study.
Over 500 patients were treated with an interferon-based regimen for advanced fibrosis or cirrhosis. Thirty-six percent of patients achieved SVR. In comparison with patients who did not achieve SVR, these patients had significantly lower 10-year cumulative rates of all-cause mortality (8.9% vs. 26%) as well as liver-related mortality or transplantation (1.9% vs. 27.4%), liver failure (2.1% vs. 29.9%), and liver cancer incidence (5.1% vs. 21.8%).